Corcept Therapeutics Inc (CORT)
23.26
+0.46
(+2.00%)
USD |
NASDAQ |
Apr 29, 15:49
Corcept Therapeutics Shares Outstanding: 103.52M for Feb. 6, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 06, 2024 | 103.52M |
December 31, 2023 | 103.40M |
October 25, 2023 | 103.08M |
September 30, 2023 | 103.00M |
July 26, 2023 | 102.55M |
June 30, 2023 | 102.51M |
April 26, 2023 | 101.58M |
April 06, 2023 | 102.21M |
March 31, 2023 | 108.16M |
February 21, 2023 | 107.90M |
December 31, 2022 | 107.84M |
October 26, 2022 | 107.65M |
July 27, 2022 | 107.11M |
June 30, 2022 | 106.66M |
April 28, 2022 | 106.25M |
April 13, 2022 | 106.25M |
March 31, 2022 | 106.22M |
February 08, 2022 | 105.96M |
December 31, 2021 | 105.94M |
October 27, 2021 | 115.45M |
September 30, 2021 | 115.30M |
July 22, 2021 | 115.93M |
June 30, 2021 | 115.82M |
April 28, 2021 | 116.63M |
April 16, 2021 | 116.63M |
Date | Value |
---|---|
March 31, 2021 | 116.48M |
February 17, 2021 | 117.31M |
December 31, 2020 | 116.74M |
October 28, 2020 | 116.17M |
September 30, 2020 | 116.17M |
July 28, 2020 | 115.56M |
June 30, 2020 | 115.55M |
April 30, 2020 | 114.60M |
April 17, 2020 | 114.60M |
March 31, 2020 | 114.60M |
February 12, 2020 | 114.59M |
December 31, 2019 | 114.55M |
November 01, 2019 | 114.28M |
September 30, 2019 | 114.11M |
July 29, 2019 | 113.69M |
June 30, 2019 | 113.64M |
May 01, 2019 | 114.86M |
April 22, 2019 | 114.83M |
March 31, 2019 | 114.93M |
February 20, 2019 | 114.72M |
December 31, 2018 | 115.03M |
October 30, 2018 | 115.47M |
August 03, 2018 | 116.05M |
May 03, 2018 | 115.24M |
April 18, 2018 | 115.24M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
101.58M
Minimum
Apr 26 2023
117.31M
Maximum
Feb 17 2021
110.74M
Average
113.90M
Median
Shares Outstanding Benchmarks
Ultragenyx Pharmaceutical Inc | 82.34M |
Alnylam Pharmaceuticals Inc | 125.95M |
Catalyst Pharmaceuticals Inc | 117.86M |
United Therapeutics Corp | 47.06M |
XOMA Corp | 11.63M |